Table 3 Comparison of survivors with non-survivors

Number, N (%)

228 (73.8%)

81 (26.2%)

Age (months, m), median (IQR)

11.5 (4.4–48.6)

16.4 (5.1–56.6)

0.264

Weight (kg)

8.6 (5.8–15.0)

10.0 (6.0–15.0)

0.440

Gender, N (%)

0.692

Male

136 (59.6%)

51 (63.0%)

Female

92 (40.4%)

30 (37.0%)

Underlying disease, N (%)

155 (68.0%)

59 (72.8%)

0.484

Reason for PICU admission, N (%)

<0.001

Medical, N (%)

135 (59.2%)

67 (82.7%)

Surgical, N (%)

93 (40.8%)

14 (17.3%)

Receipt of CRRT, N (%)

33 (14.5%)

26 (32.1%)

0.001

Receipt of vasoactive drugs, N (%)

96 (42.1%)

62 (76.5%)

<0.001

No. of vasoactive drugs, median (IQR)

0.0 (0.0–1.0)

2.0 (1.0–3.0)

<0.001

Diagnosis of MODS, N (%)

37 (16.2%)

54 (66.7%)

<0.001

PRISM-III score, median (IQR)

5.0 (2.3–9.0)

6.0 (2.0–12.5)

0.098

Time from hospital admission to PICU (days), median (IQR)

0.0 (0.0–5.0)

0.0 (0.0–3.5)

0.153

LOS in PICU (days), median (IQR)

18.0 (11.0–27.8)

16.0 (6.5–28.0)

0.088

LOS in hospital (days), median (IQR)

30.0 (20.0–46.8)

17.0 (8.0–31.5)

<0.001

Time of MV, median (IQR)

1.0 (1.0–1.0)

1.0 (1.0–1.0)

0.064

Duration of MV (days), median (IQR)

6.0 (4.0–11.0)

9.0 (5.0–22.0)

0.001

Duration of first MV (days), median (IQR)

6.0 (4.0–10.0)

9.0 (5.0–19.0)

0.001

Proportion of patients receiving MV for more than 7 days, N (%)

77 (33.8%)

47 (58.0%)

<0.001

Early FO, median (IQR)

8.1 (1.5–13.9)

7.6 (1.7–16.1)

0.992

Percentage of %FO > 10%, N (%)

98 (43.0%)

33 (40.7%)

0.794

Percentage of %FO > 20%, N (%)

15 (6.6%)

12 (14.8%)

0.037